InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions

Arnaud Bourdin (1, 2) , Gerard Criner (3) , Gilles Devouassoux (4) , Mark Dransfield (5) , David M.G. Halpin (6) , Meilan Han (7) , C. Elaine Jones (8) , Ravi Kalhan (9) , Peter Lange (10) , Sally Lettis (11) , David Lipson (12) , David Lomas (13) , José Echave-Sustaeta María-Tomé (14) , Neil Martin (15) , Fernando Martinez (16) , Holly Quasny (17) , Lynda Sail (18) , Thomas Siler (19) , Dave Singh (20) , Byron Thomashow (21) , Henrik Watz (22) , Robert Wise (23) , Nicola Hanania (24)

1 PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046]
2 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
3 Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania
4 Université de Lyon
5 Division of Pulmonary, Allergy, and Critical Care Medicine, Lung Health Center, University of Alabama at Birmingham, Birmingham, Alabama
6 University of Exeter
7 Pulmonary and Critical Care, University of Michigan, Ann Arbor, Michigan
8 GlaxoSmithKline, Research Triangle Park, North Carolina
9 Division of Pulmonary and Critical Care Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
10 UCPH - University of Copenhagen = Københavns Universitet
11 GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex,
12 Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
13 UCL - University College of London [London]
14 Respiratory Department, Hospital Universitario Quirónsalud Madrid, Universidad Europea de Madrid, Madrid
15 GlaxoSmithKline, Brentford, Middlesex
16 Weill Cornell Medicine [Cornell University]
17 GlaxoSmithKline, Research Triangle Park, North Carolina
18 GlaxoSmithKline
19 Midwest Chest Consultants, PC, St Charles, Missouri
20 The University of Manchester, Manchester University National Health Service Foundation Trust
21 Division of Pulmonary, Allergy, and Critical Care, Columbia University Medical Center, New York, New York
22 Pulmonary Research Institute at Lungen Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf
23 Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
24 BCM - Baylor College of Medicine

Domaines: Sciences du Vivant [q-bio]

Arnaud Bourdin, Gerard Criner, Gilles Devouassoux, Mark Dransfield, David M.G. Halpin, et al.. InforMing the PAthway of COPD Treatment Single-Inhaler Triple Therapy (Fluticasone Furoate/ Umeclidinium/ Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium /Vilanterol in Patients With COPD: Analysis of the Western Europe and North America Regions. Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation, 2020, ⟨10.15326/jcopdf.2020.0158⟩. ⟨hal-02995478⟩